15 May 2024
The ARC consensus on DCB - evidence-based DCB technology
Anchorperson:
P. Serruys
Summary
In this replay, discover why DCBs are essential in treating de novo CAD, the importance of optimal lesion preparation for long-term success, and how future trials will focus on treatment strategies rather than device comparisons, highlighting the need for further research.
Learning Objectives
- To learn the basics of DCB technology, including antiproliferative agents, drug transfer to the vessel wall, effective inhibitory level and duration of vessel wall retention
- To learn from the comprehensive review of the clinical evidence on DCB technology (lesion and clinical setting)
- To learn criteria for optimal lesion preparation prior to DCB application in ISR and de novo
